Evidence map›Paper›PMID 41301561›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Regulation of the Expression of

Esmeralda Cebrián-Sastre, Ángel Ruiz-Enamorado, Alfredo Castañeda-García, Susanne Gola, Pablo García-Bravo, Leonor Kremer, Jesús Blázquez

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esmeralda Cebrián-SastreDepartment of Microbial Biotechnology, National Center for Biotechnology (CNB)-CSIC, 28049 Madrid, Spain.ORCID 0000-0002-5594-387X
Ángel Ruiz-EnamoradoDepartment of Microbial Biotechnology, National Center for Biotechnology (CNB)-CSIC, 28049 Madrid, Spain.
Alfredo Castañeda-GarcíaDepartment of Microbial Biotechnology, National Center for Biotechnology (CNB)-CSIC, 28049 Madrid, Spain.
Susanne GolaDepartment of Medical Technology and Biotechnology, Ernst-Abbe-Hochschule Jena, University of Applied Sciences, 07745 Jena, Germany.
Pablo García-BravoDepartment of Microbial Biotechnology, National Center for Biotechnology (CNB)-CSIC, 28049 Madrid, Spain.
Leonor KremerDepartment of Immunology and Oncology, National Center for Biotechnology (CNB)-CSIC, 28049 Madrid, Spain.ORCID 0000-0002-2235-2010
Jesús BlázquezDepartment of Microbial Biotechnology, National Center for Biotechnology (CNB)-CSIC, 28049 Madrid, Spain.ORCID 0000-0003-0495-3848

Funding

Agencia Estatal de Investigación PCI2019-103488/AEI/10.13039/501100011033Agencia Estatal de Investigación PID2020-112865RBI00/AEI/10.13039/501100011033Instituto de Salud Carlos III FI18/00036Instituto de Salud Carlos III PI17/00159Ministerio de Ciencia, Innovación y Universidades FPU2020/01676
6 · The paper itself

Abstract

Mismatch repair (MMR) system alterations can trigger transient hypermutation, promoting adaptive mutations under stress, such as antibiotic exposure. While most organisms use MutS and MutL protein families for MMR, many archaea and actinobacteria, including the major human pathogen

Indexed as

mismatch repairMycobacteriumNucSregulation of gene expressionsigma factor σB

Identifiers

PMID41301561
PMCPMC12649562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.